LGR5 has been shown to be highly expressed in a number of cancers, including colorectal cancer [34], breast cancer [20], cervical cancer [35] and glioblastoma [36], where it is associated with positive modulation of Wnt signalling in cancer stem cells. Here, LGR5 is linked to cervical carcinoma.